LMF
ALXN

LMR Master Fund’s Alexion Pharmaceuticals ALXN Stock Holding History

LMR Master Fund’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$2.64M Buy
+19,824
New +$2.38M 0.27% 126
2013
Q3 		– Sell
-15,283
Closed -$1.41M – 456
2013
Q2 		$1.41M Buy
+15,283
New +$1.47M 0.13% 205

Other funds holding ALXN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

LMR Master Fund's ALXN Position: Q4 2013 in Review

LMR Master Fund opened a new position in Alexion Pharmaceuticals (ALXN) in Q4 2013: 19,824 shares worth $2.64M. The stake represents 0.27% of the portfolio and ranks #126 among its holdings. This is a return to the name: LMR Master Fund previously reported a position in ALXN as recently as Q2 2013.

LMR Master Fund first reported a position in ALXN in Q2 2013 and has held it in 2 quarters since. 463 funds tracked by Wall St. Rank hold ALXN as of Q4 2013.

  • LMR Master Fund held 19,824 shares of Alexion Pharmaceuticals worth $2.64M as of Q4 2013.
  • Alexion Pharmaceuticals was a new LMR Master Fund position in Q4 2013.
  • Alexion Pharmaceuticals made up 0.27% of LMR Master Fund's portfolio in Q4 2013, its #126 holding.
  • LMR Master Fund first reported a position in Alexion Pharmaceuticals in Q2 2013 and has held it in 2 quarters since.
  • 463 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.